Core Laboratories N.V. (NYSE: CLB) is a Energy company (Oil & Gas Equipment & Services) with a market capitalization of $384M. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 16, 2026), Core Laboratories N.V. had a Maz Rating of 1.42 out of 5 (D, Sell), ranked against the other companies in its sector. Its strongest factor then was Financial Health (3.26), around the middle of its sector; its weakest was Momentum (1.82), below most of its sector. The other factors: Profitability 2.47 (below most of its sector); Growth 2.09 (below most of its sector); Valuation 2.00 (more expensive than most of its sector). The current rating is for members: log in to see it.
At $8.39, Core Laboratories N.V. trades at 24.5x trailing earnings, 0.7x sales and 1.4x book value, with an EV/EBITDA of 9.7. Over the last twelve months it generated about $520M of revenue and $16M of net income. It runs a gross margin of 17.7%, an operating margin of 7.6% and a net margin of 3.0%. It shows return on equity of 5.7%, return on invested capital of 4.4% and a free cash flow yield of 5.5%. On the balance sheet: a debt-to-equity ratio of 0.58 and a current ratio of 2.19. Over the past 52 weeks the share price ranged from $8.12 to $20.36, with a beta of 1.17.
Core Laboratories N.V. pays a dividend yielding 0.48%, with 12% of earnings paid out. Its Maz Dividend Score is 2.21 out of 5, ranked against the other dividend payers in its sector (Safety 3.96, Growth 1.19, Yield 1.19, Consistency 3.13).
37 Wall Street analyst ratings cover the stock: 16 Buy, 17 Hold and 4 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction. The company's operations are distinctly segmented into Reservoir Description and Production Enhancement. The Reservoir Description division meticulously analyzes petroleum reservoir rock, fluid, and gas samples. This detailed scientific examination aims to boost the yield and enhance the recovery of oil and gas from clients' reservoirs. Offerings in this segment encompass comprehensive laboratory analysis and on-site field evaluations to determine the properties of crude oil and refined products, alongside performing proprietary and collaborative industry research studies. Conversely, the Production Enhancement segment furnishes an array of services and products vital for well completions, perforations, stimulation processes, and general production activities. This includes providing integrated diagnostic tools designed to assess the efficacy of well completions and to devise strategies for more effective enhanced oil recovery initiatives. Core Laboratories markets and sells its solutions through diverse channels, including direct sales representatives, educational seminars, industry trade exhibitions, print advertising, and a network of distributors. Established in 1936, the company boasts a significant international presence, conducting operations in approximately 50 countries, with its corporate headquarters situated in Amstelveen, the Netherlands.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
Yes. As of September 2026, Core Laboratories N.V. (CLB) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 22.4% / 30% · (Cash+Inv) / Mkt Cap (36m) 4.25% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 22.4% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 4.25% / 33% · Receivables / Mkt Cap (36m) 25.2% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 22.4% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 4.25% / 33.33% · Receivables / Mkt Cap (24m) 25.2% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 19.2% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 3.81% / 33.33% · Receivables / Avg Assets (4Q) 20.4% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| FTSE | Debt / Total Assets 18.9% / 33.33% · (Cash+ST Inv) / Total Assets 3.60% / 33.33% · (Cash+Recv) / Total Assets 25.0% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
Yes. As of September 2026, Core Laboratories N.V. (CLB) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
Yes. Core Laboratories N.V. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
Core Laboratories N.V. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.